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Abstract 
Background: Neonatal abstinence syndrome (NAS) is the set of signs and symptoms present in a 
newborn whose mother was addicted to drugs while pregnant. NAS can occur due to sudden withdrawal 
from several drugs, including opioids, benzodiazepines, methamphetamines, and caffeine. It can cause 
many different issues in the newborn, including diarrhea, tremors, fever, and seizures. While these 
specific signs and symptoms are self-limited, research is showing that these children grow in to 
childhood and adolescence with increased risk of Attention-Deficit/Hyperactivity Disorder (ADHD), 
autism, motor dysregulation, and other cognitive and behavioral sequelae.  
Purpose: The purpose of this project was to establish a correlation between a diagnosis of NAS in 
infancy and a diagnosis of ADHD later in adolescence. This was a retrospective chart review of a large 
academic health science center’s electronic health record system that identified children who had a 
diagnosis of NAS in infancy and then later received a diagnosis of ADHD. The goal of this chart review 
was to identify the prevalence of ADHD among children who were born addicted to drugs. If this data 
shows a correlation between the two conditions, it will provide the support to intervene early and to 
improve outcomes for mothers, infants and families. 
Methods: The University of Kentucky Center for Clinical and Transitional Science (CCTS) group extracted 
data from Sunrise Clinical Manager and Ambulatory Electronic Health Records to identify the samples 
needed for the study. The primary sample criterion was patients being treated at the University of 
Kentucky Neonatal Intensive Care Unit for NAS at any time from August 1st, 2008 until August 1st, 2018. 
ICD 9 and ICD 10 billing codes were then used to search this sample population for children with a 
diagnosis of ADHD, medication prescription for Guanfacine, Adderall, Ritalin (methylphenidate), and 
Focalin (dexmethylphenidate), and zip code (first 3 digits). These data points were extracted to see 
which children with NAS developed ADHD, and where these patients lived.  
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Results: 1432 patients were identified from the electronic health records as having NAS during the 
requested time range. Of these patients, 22 (1.5%) had a subsequent diagnosis of ADHD, and 31 (2.1%) 
had subsequent pharmacologic treatment with one or more of the ADHD medications. Only 157 (10.9%) 
of the patients live in Fayette County, and 329 (22.9%) live in a neighboring county. Nine hundred and 
forty six (66%) of the patients live further than two counties away from Fayette County. 
Conclusion: Current research shows a 30-60% correlation between NAS and subsequent development of 
ADHD, which is much higher than the data present in this study. Many patients with NAS that are 
treated at the University of Kentucky NICU are transferred from outside hospitals and live far away from 
Lexington, in areas where traveling to the University for primary care may not be feasible. If the patient 
doesn’t return to a University of Kentucky outpatient clinic then they were not captured in the ADHD 
data, regardless if they suffered from the condition or not. Many of the patients with NAS (up to 88.9% 
of them) live in Eastern Kentucky and may not be included in the ADHD portion of the data. As a result, 
patient education programs on the short-term and long-term effects of NAS, including the risk of ADHD 
and other developmental disorders, and early intervention services for children and families may be 
more effective in the counties where the patient and families reside. 
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Introduction 
Neonatal abstinence syndrome (NAS) is the set of signs and symptoms present in a newborn 
whose mother was suffering from substance use disorder while pregnant. NAS can occur due to 
maternal use of legal, illegal, prescribed, and non-prescribed drugs during pregnancy. Some commonly 
abused drugs include heroin, codeine, methamphetamines, methadone, antidepressants, 
benzodiazepines, and caffeine. The syndrome is becoming a major health problem in many areas of the 
United States, especially in rural and poorer states like Kentucky (Kentucky Department for Public 
Health, 2015). According to the CDC, the incidence of NAS quadrupled from 1999-2013, and Kentucky 
was one of the most strongly affected states in the nation (Duncan, 2016). Records indicate that the 
number of NAS newborns discharged from Kentucky hospitals has increased 23-fold since 2000; going 
from 46 in 2001 to 1060 in 2014 (Kentucky Department for Public Health, 2015). In one study quoted by 
Kocherlakota (2014), maternal opioid use in the United States increased from 1.2 mothers per 1,000 in 
2000 to 5.6 mothers per 1,000 in 2009. In that time, NAS cases nearly tripled, from 1.2 to 3.4 per 1,000 
births (Kocherlakota, 2014).  
 These babies can develop mild to severe withdrawal symptoms in the immediate post-natal 
period which can lead to hospitalization in the NICU. Research on the long-term effects of NAS is limited. 
However, recent studies have shown that children can develop neurocognitive delays even after 
successful detoxification in the NICU, as evidenced by heightened NICU Neurobehavioral Scale, ADHD 
Rating Scale, and Bayley Infant Record Behavior scores (Logan, Brown, & Hayes, 2014). 
 One of the neurocognitive issues that is common in individuals who suffered from NAS as 
infants is attention-deficit/hyperactivity disorder (ADHD). ADHD is a pediatric neurodevelopmental 
disorder that is marked by inattention, hyperactivity, and impulsivity (National Institute of Mental 
Health, 2019). Risk factors for ADHD include genetics; exposure to environmental toxins during 
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pregnancy or during childhood; low birth weight; and smoking, alcohol, or drug use during pregnancy 
(NIMH, 2019). Signs and symptoms of ADHD can begin as early as age 3, and can persist in to 
adolescence and early adulthood. Diagnosis of ADHD involves the identification of signs/symptoms 
involved with chronic inattention, hyperactivity, and impulsivity that interferes with school and activities 
of daily living. Some of these signs and symptoms include (NIMH, 2019): 
- Inattention: overlooking or missing details; having problems sustaining interest and 
attention in play, conversation, and reading; not being able to listen when spoken directly 
to; having problems with organization; losing things easily; being easily distracted; and being 
forgetful with daily activities. 
- Hyperactivity/Impulsivity: being fidgety while sitting; leaving their seat in situations where 
sitting is required; being unable to be quiet in situations that require it; nonstop talking; 
having trouble waiting their turn; blurting out answers and finishing other people’s 
sentences; and interrupting/intruding on other people’s games and activities.  
 As NAS rates soar, research is underway to find out how drug exposure affects the brain long-
term. According to Kocherlakota (2014), animal experiments are underway to find a connection 
between maternal opioid use and fetal brain growth. While this connection has yet to be proven or 
disproven, studies are showing that these fetuses have altered maturation of neurons and smaller 
neuroanatomic volumes, perhaps demonstrating the link between NAS and smaller head circumference 
(Kocherlakota, 2014). Kocherlakota (2014) also discusses the need for follow-up care in pediatric 
specialties related to altered CNS function, such as neurology (related to delayed motor development 
and microcephaly), ophthalmology (related to nystagmus, strabismus, and other visual defects), and 
psychiatry (related to hyperactivity, impulsivity, and ADHD).  
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Many researchers have discussed the correlation between NAS and cognitive delay in childhood. 
For example, Lall (2008) found that cocaine exposure was linked to higher rates of cerebral palsy, low IQ 
scores, increased delinquent behavior, and poor language development. In addition, Klinger et al. (2011) 
found that children with NAS have smaller head circumferences at birth, and commonly test lower on 
the Denver Developmental Screen Test 2 (DDSTII) at age 6. Also, Logan, Brown, and Hayes (2014) found 
that opioid-exposed infants scored lower on the Bayley Scaled of Infant Development (BSID) at ages 18 
and 36 months. Researchers haven’t figured out exactly why these correlations occur and what 
pathophysiologic changes precede them. However, it is important for healthcare providers to know that 
NAS is linked to cognitive issues later in life, and that they should initiate therapy and preventative 
measures early and often. 
Nygaard, Slinning, Moe, and Walhovd (2016) found that children at ages   4 ½ and 8 ½, who 
were treated for NAS were more likely to show ADHD symptoms (per the ADHD Rating Scale) than 
children who were not exposed. In Kentucky, teachers are beginning to notice these signs and symptoms 
earlier and more often in Kindergarten-aged children. A Director of Advocacy for the Kentucky School 
Board Association notes that educators in the state are “seeing the first generation of children enter our 
schools in Kentucky, in Kindergarten and first grade that were born with NAS resulting from the current 
opioid crisis”. These children have significant developmental delays that directly correlate with NAS 
rates (Acquisito and Spears, 2019). This trend is resulting in more children with behavioral issues and 
more children needing special education services in the school system (Acquisito and Spears, 2019).  
 Drug abuse is becoming a major health problem, and as a result NAS rates are rapidly increasing. 
In 2014, Kentucky NICUs saw a 7% increase in NAS visits (Duncan, 2016), and it is becoming a major 
problem in poorer/rural states where opioid addiction is at an all-time high. Researchers are learning 
more about the sequelae of NAS in older children, and pediatric primary care providers have a 
responsibility to treat these conditions as early as possible to prevent developmental delays in children 
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as they age. ADHD is one of the conditions commonly found in children with a history of NAS (Richards-
Gustafson, 2017), and after synthesizing the evidence, it is clear that there is a correlation between the 
two. This correlation can provide the basis for evidence-based education programs aimed at preventing 
and treating children and families that have experienced NAS.  
Research Barriers 
 Research on the correlation between NAS and ADHD is limited, in large part because many 
factors may contribute to developmental and cognitive delays in childhood. According to Acquisito and 
Spears, “certain developmental delays and disabilities are a consequence of the opioid crisis, but we 
don’t know which piece” (Acquisito and Spears, 2019, pg. 4). Other socioeconomic factors that may 
contribute to developmental and cognitive delays include parents’ financial instability, unsafe housing, 
abuse, incarceration, and being in the care of foster or adoptive parents.  
 The University of Kentucky Neonatal Intensive Care Unit (NICU) is one of the only NICU’s in 
Kentucky that treats NAS. In general, any baby suffering from NAS who is delivered at a hospital in 
Eastern/Appalachia Kentucky will be transferred to the University of Kentucky hospital for a higher level 
of care. The University of Kentucky hospital provides higher acuity care than most Eastern Kentucky 
hospitals, but this transfer may create socioeconomic strains on the family, which can be especially 
difficult given the conditions that many of the people in that region face already. The number of babies 
born with NAS in Eastern/Appalachian Kentucky as high as 65 cases per 1,000 live births; nearly 3 times 
higher than the Kentucky rate of 22 cases per 1,000 live births (Acquisito & Spears, 2019). This places a 
significant strain on the parents of children with NAS in this area, as well as on the University of 
Kentucky NICU staff. Many of these families are inconvenienced by their child receiving care in a hospital 
that may be hours away from home. These families may not return to the hospital for follow-up care, 
and that may exacerbate efforts for follow-up care of these children. Research suggests that patients 
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will not travel further than 20-30 miles for routine primary care (Yen, 2013), so it can be assumed that 
many of the patients treated for NAS at UK Healthcare will be lost to outside hospitals and clinics for 
follow-up care. 
 
Purpose 
 The purpose of this project was to determine if there was a correlation between NAS and ADHD 
at a large university hospital. The literature makes it clear that children with NAS often suffer from long-
term cognitive and developmental complications. Unfortunately, the same research shows that the 
causes and correlations are not easily identifiable. This DNP project was a retrospective chart review 
aimed at identifying a correlation between NAS and ADHD. Electronic health records at a large university 
hospital were searched for key words and ICD codes to identify children who were treated at the 
hospital for NAS, and of those children, which ones went on to have a diagnosis of ADHD. The goal of 
this search is to provide tangible evidence of a correlation between NAS and ADHD. These data can be 
the foundation for evidence-based education programs aimed at helping children and families with NAS. 
 
Methods 
 The data were extracted from the electronic health record with the help of the Center for 
Clinical and Transitional Science (CCTS) group. De-identified data that met the inclusion and exclusion 
criteria were extracted. ICD 9 and ICD 10 codes were used as the basis for the inclusion criteria search. 
The following codes were used in the data search: 
- ICD-9 diagnosis codes: 
o 779.5 – drug withdrawal syndrome in the newborn 
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o 314.01 – attention deficit disorder without mention of hyperactivity 
o 314.01 – attention deficit disorder with hyperactivity 
- ICD-10 diagnosis codes: 
o P96.1 – neonatal withdrawal symptoms from maternal use of drugs of addiction 
o F90.0 – attention-deficit hyperactivity disorder, predominantly inattentive type 
o F90.2 – attention-deficit hyperactivity disorder, combined type 
o F90.9 – attention-deficit hyperactivity disorder, unspecified type 
The primary inclusion criterion, which provided the total sample population of the study, was a 
diagnosis of NAS within the date range of August 1st 2008 to August 1st 2018. From this population, the 
following secondary inclusion criteria were extracted: diagnosis of ADHD, medication prescription for 
Guanfacine, Adderall, Ritalin (methylphenidate), Focalin (dexmethylphenidate), and zip code. 
Institutional Review Board (IRB) approval for this project was obtained on October 8th, 2019.  
Setting and Sample 
 This retrospective chart review was conducted by the University of Kentucky Center for Clinical 
and Translation Science (CCTS) and was exported from Sunrise Clinical Manager and Ambulatory 
Electronic Health Record, both of which are electronic health database systems utilized by the 
University. It involved a search for every child that was treated for Neonatal Abstinence Syndrome (NAS) 
in the University of Kentucky NICU for a 10-year period beginning August 1st, 2008 and ending August 1st, 
2018. Acquisito and Spears (2019) estimate that the opioid crisis in Kentucky began around 2009, which 
is why this 10-year period was used for the chart review. In total, 1432 NAS babies were isolated from 
the CCTS database search. This was the sample that was used to search for the necessary inclusion 
criteria. 
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Theoretical Framework  
NAS can be considered a tertiary result of maternal drug use: the mother develops an addiction 
to a drug, the mother uses the drug before and/or during pregnancy, and as a result the child is born 
addicted to the drug. If proper primary and secondary preventions are implemented, NAS can be 
prevented (Hamdan, 2017). Drug cessation, proper prenatal care, and proper treatment for pregnant 
women with substance use disorders can eliminate or quell the signs and symptoms of NAS. Addiction is 
a multifaceted condition, and Neuman’s Systems Model can provide a framework for treating this 
problem. Neuman’s model focuses on a person’s reaction to stress, and uses a multidimensional and 
holistic approach in treating it (Fulbrook, 1991). The major concepts of the model include the person, 
the environment, health, and nursing, and Neuman emphasizes that primary, secondary, and tertiary 
care may all be required in the treatment of a given condition (Fulbrook, 1991). Care of the mother who 
has been addicted to opioids, care of the baby with NAS, and prevention of complications later in life 
involve all of these factors.  
 
Results 
Of the 1432 children in the sample population, 832 (58.1%) infants were male and 600 (41.9%) 
were female. Many different races were represented, but the majority of them were Caucasian (1331, 
92.9%). The most surprising statistic to come from the data search was that only 22 (1.5%) children had a 
diagnosis of ADHD. In addition, 31 (2.1%) children were prescribed an ADHD medication. These were 
children seen at UK Health Care clinics who did not have an ADHD diagnosis through UK Health Care, but 
were prescribed an ADHD medication there. These children were likely diagnosed with ADHD at an outside 
facility but were seen at UK Health Care for an unrelated issue. The preceding statistics show that at most, 
53 (3.6%) children in the NAS population sample developed an ADHD diagnosis. This data is clearly 
NAS and ADHD                                                                                                                                                                
   
8 
 
inconsistent with current evidence-based research. At this point, zip codes were added to the inclusion 
criteria to examine where these patients with NAS live. The University of Kentucky NICU is one of the 
primary NAS treatment centers in the state, and many families may have to travel a long way from home 
while their babies are being treated. Many of these children may not ever return to the University of 
Kentucky for primary care treatment, which is why county of residence played a role in the interpretation 
of the data. Interestingly, the zip code data shows that most of the children in the population sample live 
in areas outside of Lexington:  
- 157 (10.9%) children were from Lexington  
- 329 (22.9%) children resided in a county that is within 2 counties of Fayette County KY 
- 42 (2.9%) children live in counties west of Fayette County KY 
- 295 (20.6%) children live in counties that are north or south of Fayette County KY and its 
surrounding counties 
- Between 514 and 823 (36-58.8%) children live in counties east of Fayette County.  
 
Discussion 
More than 61.9% of the children in this study live further than one county away from Fayette 
County. This was a large portion of the sample size. Current evidence-based research estimates the rate 
of ADHD among babies with NAS to be anywhere from 30-40%, much higher than the 3.6% estimated in 
this study. Children are being discharged from the University of Kentucky Hospital to homes that are 
several counties away, and they never return to this hospital or primary care clinics within the university 
healthcare system, and were not be captured in this study.  
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Implications for Practice 
 As the opioid crisis gets worse, the number of NAS cases in the United States increases. NAS is 
not a new diagnosis; however, studies on the long-term effects of NAS are limited. The goal of this 
project was to see if a link between NAS and ADHD exists in hopes of expanding the literature. These 
data could be beneficial to providers in many areas, including general pediatrics, behavioral and 
developmental pediatrics, and OB-GYN. A few ways that this research could help providers within the 
university setting include: 
- General Pediatrics: Identify children who may be at risk for ADHD due to a verified history of 
NAS. Pediatric providers could begin teaching the parent about the early signs and 
symptoms of ADHD in kids who may be at risk. Programs, such as the Incredible Years 
Parenting Program, which is an evidence-based parenting program, could be beneficial in 
helping families and be delivered in primary care offices where these families reside. 
- OB-GYN: If the OB-GYN knows that the mother has a history of drug use, and if they suspect 
that they will deliver a baby with NAS, the OB-GYN could begin patient education on the 
signs/symptoms of withdrawal and other helpful evidence-based interventions. 
- Family practitioners and drug counselors: This project highlights the importance of providing 
evidence-based treatments to support mothers to stop using drugs. A campaign aimed at 
women during childbearing years may help to decrease drug use and prevent NAS. 
Current evidence-based research is showing improved NAS outcomes from effective antidrug 
education during pregnancy and before conception. Education aimed at getting mothers to stop taking 
drugs during pregnancy would have a direct and positive impact on babies. NAS can be reduced or even 
eliminated with effective primary care either early in pregnancy or pre-conception (Ko et al., 2017). 
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Nearly 86% of pregnancies involving mothers with opioid addiction are unintentional, so NAS education 
must occur quickly and as soon as the mother begins seeking prenatal care (Ko et al., 2017).  
 Data from this project shows that a large percentage of children with NAS live in eastern 
Kentucky. Therefore, providing services and interventions in this area may improve outcomes for these 
children. Infants with NAS who are raised by their biological families tend to score lower on the Bayley 
Scales of Infant Developmental-Mental Developmental Index (Shearer et al., 2018). In addition, infants 
with NAS who live in homes with lower socioeconomic status were much more likely to score lower on 
multiple developmental tests than those in homes with average to high socioeconomic status (Shearer 
et al., 2018). Intellectual outcomes were similar to developmental outcomes: infants with NAS were 
much more likely to suffer from intellectual disabilities at one year, 18 months, and three years, and 7th 
graders with NAS tend to score less than or at a 5th grade level on standardized tests (Shearer et al., 
2018). Babies with NAS are more likely to be born with smaller head circumferences and have abnormal 
MRI scans, as evidenced by decreased volumes of basal ganglia and cerebellar white matter, at ages 10-
14 (Shearer et al., 2018). Babies with NAS may have cognitive and developmental delays. These issues 
are compounded when they occur in rural, poor areas like Eastern and Appalachian Kentucky.  
Eastern Kentucky is one of the poorest economic regions in the country. Of all the counties that 
lie east of I-75, 36 of them are considered ‘distressed’ by a survey conducted by the Appalachian 
Regional Commission of the U.S. Census Bureau (see Appendix C). The area is among the poorest and 
most rural in the nation, and median household income is well below the national average in nearly 
every county. These socioeconomic factors, when combined with higher rates of opioid use, compound 
the effects of NAS on children growing up in these areas. As many as 25% of children with opioid 
exposure may not receive necessary healthcare within the first 2 years of life (Shearer et al., 2018).  
Further, children with NAS who grow up with mothers who suffer from substance use disorder are much 
more likely to develop mental health disorders as adults, and this correlation can predict future drug use 
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by up to 50% (Shearer et al., 2018). Considering these facts, as well as the facts present throughout this 
study, Eastern Kentucky is an area that may benefit from NAS education. Through the University of 
Kentucky’s Area Health Education Centers (AHEC), delegates from the university work to train, support, 
and recruit effective healthcare providers in all areas of the state. Nearly 60% of babies with NAS seen at 
the University of Kentucky NICU reside in counties within the Northeast and Southeast AHEC’s (see 
Appendix A). Healthcare professionals in these areas should be trained about NAS, its signs and 
symptoms, and how to properly treat and wean mothers with substance use disorder who are pregnant 
or thinking about becoming pregnant. This education should include the importance of weaning off 
drugs as soon as they know they are pregnant, the use of Subutex programs, and the short and long-
term consequences of NAS (if they choose to continue using drugs). 
Limitations 
The major limitation of this study is that children who were not seen for follow-up ADHD 
treatment were not included in the results. If a child was treated for NAS at UK Healthcare, but never 
returned to UK for follow-up care or received their ADHD diagnosis at an outside clinic, the ICD 9 and 
ICD 10 codes for their diagnoses were not captured in the follow-up data. If it had been somehow 
possible to track these children at their respective healthcare facilities, ADHD rates for this study may 
have been more consistent with nation-wide studies that show a much higher incidence. 
 
Conclusion 
Neonatal abstinence syndrome isn’t a new health problem, but it is becoming more common 
due to the worsening opioid crisis in the United States. The long-term effects of the condition are not 
well studied, but data suggests that children are developing chronic developmental, behavioral, and 
cognitive problems. These conditions have origins that may be hard to pinpoint, because there may be 
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many contributing factors: socioeconomic status, wealth, living conditions, marital status, and access to 
quality healthcare are just a few factors that may initiate or exacerbate cognitive and developmental 
changes to the brain. Data, as well as first-hand accounts from teachers, parents, and healthcare 
providers in high risk areas are seeing an increase in children with developmental delays, behavioral 
problems, and the need for special education services. While it isn’t possible to label NAS as the only or 
major cause, it is certainly possible to assume that it is a major causative factor.  
NAS is the result of drug use during pregnancy, and it can be completely avoided in parents who 
do not use these substances, or in those who cease using these substances once they become pregnant. 
The major goal of patient education is to enlighten people and promote change, and NAS is a condition 
that can be prevented with proper prenatal and pre-pregnancy patient education. This education should 
focus on the short and long-term consequences of the condition, ranging from the gastrointestinal and 
neurologic withdrawal symptoms present at birth to the potential developmental and cognitive 
deficiencies noted in school aged and adolescent children. Eliminating NAS would have a profound 
impact on patient outcomes, especially in poor and disadvantaged areas, as well as promote cost 
savings in a variety of healthcare areas. Kentucky is one of the poorest and most rural states in the 
country, and likewise opioid use and NAS rates are very high in many areas of the state. As a leader of 
healthcare in Kentucky, and as one of the only NAS treatment centers in the state, the University of 
Kentucky, through outreach programs, can impact the community where NAS rates are prevalent and 
improve outcomes for children and families living within the state. 
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Appendix A 
Map of Kentucky Area Health Education Centers 
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Appendix B 
Distribution of University of Kentucky Babies with NAS in Kentucky Zip Codes 
 
 
 
< 10 Children = GRAY 
11-20 Children = GREEN 
21-40 Children = YELLOW 
41-60 Children = ORANGE 
61-100 Children = RED 
> 100 Children = BLACK 
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Appendix C 
Appalachian County Economic Levels 
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Appendix D 
Data Tables from CCTS Chart Extract 
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ZIP CODE COUNT 
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Appendix E 
 
 
 
 
APA Citation Purpose 
Statement 
Study Design Sample Key Findings 
Sandtorv, L.B., Fevang, S.K.E., 
Nilsen, S.A., Boe, T., Gjestad, R., 
Haugland, S., and Elgen. I.B. 
(2018). Symptoms Associated 
With Attention 
Deficit/Hyperactivity Disorder 
and Autism Spectrum Disorders 
in School-Aged Children 
Prenatally Exposed to 
Substances 
To evaluate 
the mental 
health 
symptoms 
associated 
with prenatal 
substance 
abuse 
Cross-sectional  57 children, ages 6-14, from 
a large hospital in Norway, 
who were exposed to illicit 
drugs in-utero 
37% of the children 
presented with high 
risk symptoms of 
ADHD based on the 
SNAP-IV 
Nygaard, E., Slinning, K., Moe, 
V., and Walhovd, K.B. (2016). 
Behavior and Attention 
Problems in Eight-Year-Old 
Children with Prenatal Opiate 
and Poly-Substance Exposure: A 
Longitudinal Study 
  
To investigate 
whether 
behavior and 
attention 
problems are 
more 
prominent in 
children who 
were exposed 
to drugs 
prenatally.  
Longitudinal 136 infants (78 who were 
exposed in utero and 58 
who were not exposed) 
were recruited from a large 
hospital in Norway. Their 
development was followed 
until age 8 ½. The ADHD 
rating scale was used at age 
4 ½ and at age 8 ½.  
25% of the at-risk 
children had scores 
that were indicative 
of ADHD, and an 
additional 17%  had 
scores suggesting 
ADHD-related 
problems. 
Simes, E., Oltedal, L., Bartsch, 
H., Eide, G.E., Elgin, I.B., and 
Aukland, S.M. (2017). Brain 
morphology in school-aged 
children with prenatal opioid 
exposure: A structural MRI 
study. Early Human 
Development. 106: 33-39.  
To investigate 
the association 
between 
prenatal opioid 
exposure and 
brain 
morphology in 
school-aged 
children. 
A cross-sectional 
study of prenatally 
opioid-exposed 
children 
A sample of 16 children, 
aged 10-14 with prenatal 
exposure to opioids 
Volumes of the basal 
ganglia, thalamus, 
and white matter 
were reduced in the 
opioid-exposed 
group.  
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APA Citation Purpose Statement Study Design Sample Key Findings 
Klinger, G., 
Frankenthal, D., 
Merlob, P., Diamond, 
G., Sirota, L., Levinson-
Castiel, R., Linder, N., 
Stahl, B., and Inbar, D. 
(2011). Long-term 
outcome following 
selective serotonin 
reuptake inhibitor 
induced neonatal 
abstinence syndrome 
To assess the 
neurodevelopment 
outcomes of children 
exposed to SSRI’s in 
utero that developed 
a neonatal 
abstinence syndrome 
Prospective 
cohort design 
30 children with 
NAS and 52 
children without 
NAS were recruited 
from a large Israeli 
hospital. 
27% of the children with NAS had 
lingual abnormalities and 47% of 
the children with NAS had social 
abnormalities (based on the Denver 
Developmental test) 
Yeoh, S.L., Eastwood, 
J., and Wright, I.M. 
(2019). Cognitive and 
motor outcomes of 
children with prenatal 
opioid exposure.  
Key Question: is 
prenatal opioid 
exposure associated 
with differences in 
childhood cognitive 
and motor 
development? 
Systemic 
review and 
meta-analysis 
of cohort 
studies 
involving 
children with 
prenatal 
opioid 
exposure 
Meta-analysis of 26 
studies, which 
included 1455 
children exposed to 
prenatal opioids 
Up to 6.3% of children with prenatal 
opioid exposure will have an IQ 
score 2 standard deviations below 
normal, compared to 2.3% of 
normal children. Thus, these 
children are 3 times more likely to 
have a severe intellectual disability 
based on DSM-5 criteria 
Nygaard, E., Slinning, 
K., Moe, V., and 
Walhovd, B. (2015). 
Cognitive function of 
youths born to 
mothers with opioid 
and poly-substance 
abuse problems 
during pregnancy 
To evaluate the 
outcomes of children 
exposed to drugs 
prenatally 
Longitudinal 
study 
45 children born to 
mothers who were 
poly-substance 
users and 48 
children who were 
born without 
prenatal exposure.  
Participants were 
administered 10 
neuropsychologic 
tests between ages 
17-21 
36% of the children in the at risk 
group were diagnosed with ADHD 
at some point in childhood.  
13% of people in the risk group 
developed substance abuse or 
addictions in their teens 
